Geode Capital Management, LLC Taro Pharmaceutical Industries LTD Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$40.97 - $43.33 $45,927 - $48,572	1,121 Added 1.21%	93,934 $3.98 Million
Q4 2023 Feb 13, 2024	BUY	$32.77 - $42.31 $142,221 - $183,625	4,340 Added 4.91%	92,813 $3.88 Million
Q3 2023 Nov 13, 2023	BUY	$35.46 - $40.13 $210,526 - $238,251	5,937 Added 7.19%	88,473 $3.34 Million
Q2 2023 Aug 11, 2023	BUY	$24.24 - $40.97 $2 Million - $3.38 Million	82,536 New	82,536 $3.13 Million
Q1 2020 May 14, 2020	SELL	$59.35 - $88.73 $454,027 - $678,784	-7,650 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$74.18 - $97.92 $800,105 - $1.06 Million	-10,786 Reduced 58.51%	7,650 $671,000
Q3 2019 Nov 12, 2019	BUY	$75.36 - $86.57 $206,712 - $237,461	2,743 Added 17.48%	18,436 $1.39 Million
Q2 2019 Aug 14, 2019	BUY	$83.92 - $108.88 $384,857 - $499,323	4,586 Added 41.29%	15,693 $1.34 Million
Q1 2019 May 14, 2019	BUY	$85.97 - $108.09 $331,156 - $416,362	3,852 Added 53.09%	11,107 $1.2 Million
Q4 2018 Feb 13, 2019	BUY	$78.25 - $107.92 $314,408 - $433,622	4,018 Added 124.13%	7,255 $613,000
Q3 2018 Nov 13, 2018	BUY	$97.82 - $116.09 $38,932 - $46,203	398 Added 14.02%	3,237 $318,000
Q2 2018 Aug 14, 2018	BUY	$97.62 - $120.59 $33,874 - $41,844	347 Added 13.92%	2,839 $327,000
Q1 2018 May 15, 2018	SELL	$95.91 - $107.26 $230,759 - $258,067	-2,406 Reduced 49.12%	2,492 $245,000
Q4 2017 Feb 13, 2018	SELL	$104.5 - $126.38 $3.21 Million - $3.88 Million	-30,739 Reduced 86.26%	4,898 $511,000
Q3 2017 Nov 14, 2017	BUY	$97.26 - $116.2 $38,709 - $46,247	398 Added 1.13%	35,637 $4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	35,239	35,239 $3.94 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account